EP3539555 - THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 05.11.2021 Database last updated on 26.06.2024 | |
Former | The patent has been granted Status updated on 27.11.2020 | ||
Former | Grant of patent is intended Status updated on 20.07.2020 | ||
Former | Request for examination was made Status updated on 20.03.2020 | ||
Former | The application has been published Status updated on 16.08.2019 | Most recent event Tooltip | 14.06.2024 | Lapse of the patent in a contracting state New state(s): TR | published on 17.07.2024 [2024/29] | Applicant(s) | For all designated states Kai Pharmaceuticals, Inc. 270 Littlefield Avenue South San Francisco, CA 94080 / US | [2019/38] | Inventor(s) | 01 /
KARIM, Felix 732 Laurel Drive Walnut Creek, CA 94596 / US | 02 /
BARUCH, Amos 1535 Funston Avenue San Francisco, CA 94112 / US | 03 /
MACLEAN, Derek 750 Jordan Avenue Los Altos, CA 94022 / US | 04 /
DAS, Kanad 1125 Holloway Avenue San Francisco, CA 94132 / US | 05 /
YIN, Qun 747 Coastland Drive Palo Alto, CA 94030 / US | [2019/38] | Representative(s) | Gibson, Mark Sagittarius IP Marlow International Parkway Marlow SL7 1YL / GB | [2019/38] | Application number, filing date | 19159337.5 | 29.07.2010 | [2019/38] | Priority number, date | US200922969509P | 29.07.2009 Original published format: US 22969509 P | US200925581609P | 28.10.2009 Original published format: US 25581609 P | US201031363510P | 12.03.2010 Original published format: US 31363510 P | [2019/38] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | EP3539555 | Date: | 18.09.2019 | Language: | EN | [2019/38] | Type: | B1 Patent specification | No.: | EP3539555 | Date: | 30.12.2020 | Language: | EN | [2020/53] | Search report(s) | (Supplementary) European search report - dispatched on: | EP | 13.08.2019 | Classification | IPC: | A61K38/08, C07K7/06, A61P3/14, A61P5/20, A61P5/00 | [2019/38] | CPC: |
C07K7/06 (EP,CN,KR,US);
A61K31/59 (KR);
A61K47/60 (EP,US);
A61K9/0019 (EP,CN,US);
A61K9/08 (EP,CN,US);
A61P13/12 (EP,KR);
A61P3/00 (EP);
A61P3/14 (EP);
A61P43/00 (EP);
A61P5/00 (EP);
A61P5/14 (EP);
A61P5/18 (EP);
A61P5/20 (EP);
C07K5/1013 (EP,CN,US);
C07K7/08 (EP,CN,US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR [2020/17] |
Former [2019/38] | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, SE, SI, SK, SM, TR | Title | German: | THERAPIEMITTEL ZUR REDUZIERUNG DER NEBENSCHILDDRÜSENHORMONSPIEGEL | [2019/38] | English: | THERAPEUTIC AGENTS FOR REDUCING PARATHYROID HORMONE LEVELS | [2019/38] | French: | AGENTS THÉRAPEUTIQUES DE RÉDUCTION DES NIVEAUX D'HORMONE PARATHYROÏDE | [2019/38] | Examination procedure | 16.03.2020 | Amendment by applicant (claims and/or description) | 16.03.2020 | Examination requested [2020/17] | 16.03.2020 | Date on which the examining division has become responsible | 21.07.2020 | Communication of intention to grant the patent | 20.11.2020 | Fee for grant paid | 20.11.2020 | Fee for publishing/printing paid | 20.11.2020 | Receipt of the translation of the claim(s) | Parent application(s) Tooltip | EP10805078.2 / EP2459208 | EP16190682.1 / EP3192520 | Divisional application(s) | EP20209086.6 / EP3808363 | EP22193946.5 / EP4154900 | Opposition(s) | 01.10.2021 | No opposition filed within time limit [2021/49] | Fees paid | Renewal fee | 26.02.2019 | Renewal fee patent year 03 | 26.02.2019 | Renewal fee patent year 04 | 26.02.2019 | Renewal fee patent year 05 | 26.02.2019 | Renewal fee patent year 06 | 26.02.2019 | Renewal fee patent year 07 | 26.02.2019 | Renewal fee patent year 08 | 26.02.2019 | Renewal fee patent year 09 | 15.07.2019 | Renewal fee patent year 10 | 14.07.2020 | Renewal fee patent year 11 |
Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | HU | 29.07.2010 | AL | 30.12.2020 | AT | 30.12.2020 | CY | 30.12.2020 | CZ | 30.12.2020 | DK | 30.12.2020 | EE | 30.12.2020 | ES | 30.12.2020 | FI | 30.12.2020 | HR | 30.12.2020 | IT | 30.12.2020 | LT | 30.12.2020 | LV | 30.12.2020 | MC | 30.12.2020 | MK | 30.12.2020 | NL | 30.12.2020 | PL | 30.12.2020 | RO | 30.12.2020 | SE | 30.12.2020 | SI | 30.12.2020 | SK | 30.12.2020 | SM | 30.12.2020 | TR | 30.12.2020 | BG | 30.03.2021 | NO | 30.03.2021 | GR | 31.03.2021 | IS | 30.04.2021 | PT | 30.04.2021 | IE | 29.07.2021 | LU | 29.07.2021 | BE | 31.07.2021 | [2024/29] |
Former [2024/23] | HU | 29.07.2010 | |
AL | 30.12.2020 | ||
AT | 30.12.2020 | ||
CY | 30.12.2020 | ||
CZ | 30.12.2020 | ||
DK | 30.12.2020 | ||
EE | 30.12.2020 | ||
ES | 30.12.2020 | ||
FI | 30.12.2020 | ||
HR | 30.12.2020 | ||
IT | 30.12.2020 | ||
LT | 30.12.2020 | ||
LV | 30.12.2020 | ||
MC | 30.12.2020 | ||
MK | 30.12.2020 | ||
NL | 30.12.2020 | ||
PL | 30.12.2020 | ||
RO | 30.12.2020 | ||
SE | 30.12.2020 | ||
SI | 30.12.2020 | ||
SK | 30.12.2020 | ||
SM | 30.12.2020 | ||
BG | 30.03.2021 | ||
NO | 30.03.2021 | ||
GR | 31.03.2021 | ||
IS | 30.04.2021 | ||
PT | 30.04.2021 | ||
IE | 29.07.2021 | ||
LU | 29.07.2021 | ||
BE | 31.07.2021 | ||
Former [2023/33] | HU | 29.07.2010 | |
AL | 30.12.2020 | ||
AT | 30.12.2020 | ||
CY | 30.12.2020 | ||
CZ | 30.12.2020 | ||
DK | 30.12.2020 | ||
EE | 30.12.2020 | ||
ES | 30.12.2020 | ||
FI | 30.12.2020 | ||
HR | 30.12.2020 | ||
IT | 30.12.2020 | ||
LT | 30.12.2020 | ||
LV | 30.12.2020 | ||
MC | 30.12.2020 | ||
NL | 30.12.2020 | ||
PL | 30.12.2020 | ||
RO | 30.12.2020 | ||
SE | 30.12.2020 | ||
SI | 30.12.2020 | ||
SK | 30.12.2020 | ||
SM | 30.12.2020 | ||
BG | 30.03.2021 | ||
NO | 30.03.2021 | ||
GR | 31.03.2021 | ||
IS | 30.04.2021 | ||
PT | 30.04.2021 | ||
IE | 29.07.2021 | ||
LU | 29.07.2021 | ||
BE | 31.07.2021 | ||
Former [2023/29] | AL | 30.12.2020 | |
AT | 30.12.2020 | ||
CY | 30.12.2020 | ||
CZ | 30.12.2020 | ||
DK | 30.12.2020 | ||
EE | 30.12.2020 | ||
ES | 30.12.2020 | ||
FI | 30.12.2020 | ||
HR | 30.12.2020 | ||
IT | 30.12.2020 | ||
LT | 30.12.2020 | ||
LV | 30.12.2020 | ||
MC | 30.12.2020 | ||
NL | 30.12.2020 | ||
PL | 30.12.2020 | ||
RO | 30.12.2020 | ||
SE | 30.12.2020 | ||
SI | 30.12.2020 | ||
SK | 30.12.2020 | ||
BG | 30.03.2021 | ||
NO | 30.03.2021 | ||
GR | 31.03.2021 | ||
IS | 30.04.2021 | ||
PT | 30.04.2021 | ||
IE | 29.07.2021 | ||
LU | 29.07.2021 | ||
BE | 31.07.2021 | ||
Former [2023/24] | AL | 30.12.2020 | |
AT | 30.12.2020 | ||
CY | 30.12.2020 | ||
CZ | 30.12.2020 | ||
DK | 30.12.2020 | ||
EE | 30.12.2020 | ||
ES | 30.12.2020 | ||
FI | 30.12.2020 | ||
HR | 30.12.2020 | ||
IT | 30.12.2020 | ||
LT | 30.12.2020 | ||
LV | 30.12.2020 | ||
MC | 30.12.2020 | ||
PL | 30.12.2020 | ||
RO | 30.12.2020 | ||
SE | 30.12.2020 | ||
SI | 30.12.2020 | ||
SK | 30.12.2020 | ||
BG | 30.03.2021 | ||
NO | 30.03.2021 | ||
GR | 31.03.2021 | ||
IS | 30.04.2021 | ||
PT | 30.04.2021 | ||
IE | 29.07.2021 | ||
LU | 29.07.2021 | ||
BE | 31.07.2021 | ||
Former [2022/35] | AL | 30.12.2020 | |
AT | 30.12.2020 | ||
CZ | 30.12.2020 | ||
DK | 30.12.2020 | ||
EE | 30.12.2020 | ||
ES | 30.12.2020 | ||
FI | 30.12.2020 | ||
HR | 30.12.2020 | ||
IT | 30.12.2020 | ||
LT | 30.12.2020 | ||
LV | 30.12.2020 | ||
MC | 30.12.2020 | ||
PL | 30.12.2020 | ||
RO | 30.12.2020 | ||
SE | 30.12.2020 | ||
SI | 30.12.2020 | ||
SK | 30.12.2020 | ||
BG | 30.03.2021 | ||
NO | 30.03.2021 | ||
GR | 31.03.2021 | ||
IS | 30.04.2021 | ||
PT | 30.04.2021 | ||
IE | 29.07.2021 | ||
LU | 29.07.2021 | ||
BE | 31.07.2021 | ||
Former [2022/34] | AL | 30.12.2020 | |
AT | 30.12.2020 | ||
CZ | 30.12.2020 | ||
DK | 30.12.2020 | ||
EE | 30.12.2020 | ||
ES | 30.12.2020 | ||
FI | 30.12.2020 | ||
HR | 30.12.2020 | ||
IT | 30.12.2020 | ||
LT | 30.12.2020 | ||
LV | 30.12.2020 | ||
MC | 30.12.2020 | ||
PL | 30.12.2020 | ||
RO | 30.12.2020 | ||
SE | 30.12.2020 | ||
SI | 30.12.2020 | ||
SK | 30.12.2020 | ||
BG | 30.03.2021 | ||
NO | 30.03.2021 | ||
GR | 31.03.2021 | ||
IS | 30.04.2021 | ||
PT | 30.04.2021 | ||
LU | 29.07.2021 | ||
BE | 31.07.2021 | ||
Former [2022/23] | AL | 30.12.2020 | |
AT | 30.12.2020 | ||
CZ | 30.12.2020 | ||
DK | 30.12.2020 | ||
EE | 30.12.2020 | ||
ES | 30.12.2020 | ||
FI | 30.12.2020 | ||
HR | 30.12.2020 | ||
IT | 30.12.2020 | ||
LT | 30.12.2020 | ||
LV | 30.12.2020 | ||
MC | 30.12.2020 | ||
PL | 30.12.2020 | ||
RO | 30.12.2020 | ||
SE | 30.12.2020 | ||
SI | 30.12.2020 | ||
SK | 30.12.2020 | ||
BG | 30.03.2021 | ||
NO | 30.03.2021 | ||
GR | 31.03.2021 | ||
IS | 30.04.2021 | ||
PT | 30.04.2021 | ||
LU | 29.07.2021 | ||
Former [2022/18] | AL | 30.12.2020 | |
AT | 30.12.2020 | ||
CZ | 30.12.2020 | ||
DK | 30.12.2020 | ||
EE | 30.12.2020 | ||
ES | 30.12.2020 | ||
FI | 30.12.2020 | ||
HR | 30.12.2020 | ||
IT | 30.12.2020 | ||
LT | 30.12.2020 | ||
LV | 30.12.2020 | ||
MC | 30.12.2020 | ||
PL | 30.12.2020 | ||
RO | 30.12.2020 | ||
SE | 30.12.2020 | ||
SI | 30.12.2020 | ||
SK | 30.12.2020 | ||
BG | 30.03.2021 | ||
NO | 30.03.2021 | ||
GR | 31.03.2021 | ||
PT | 30.04.2021 | ||
Former [2022/13] | AL | 30.12.2020 | |
AT | 30.12.2020 | ||
CZ | 30.12.2020 | ||
DK | 30.12.2020 | ||
EE | 30.12.2020 | ||
ES | 30.12.2020 | ||
FI | 30.12.2020 | ||
HR | 30.12.2020 | ||
IT | 30.12.2020 | ||
LT | 30.12.2020 | ||
LV | 30.12.2020 | ||
PL | 30.12.2020 | ||
RO | 30.12.2020 | ||
SE | 30.12.2020 | ||
SI | 30.12.2020 | ||
SK | 30.12.2020 | ||
BG | 30.03.2021 | ||
NO | 30.03.2021 | ||
GR | 31.03.2021 | ||
PT | 30.04.2021 | ||
Former [2022/10] | AL | 30.12.2020 | |
AT | 30.12.2020 | ||
CZ | 30.12.2020 | ||
DK | 30.12.2020 | ||
EE | 30.12.2020 | ||
ES | 30.12.2020 | ||
FI | 30.12.2020 | ||
HR | 30.12.2020 | ||
IT | 30.12.2020 | ||
LT | 30.12.2020 | ||
LV | 30.12.2020 | ||
PL | 30.12.2020 | ||
RO | 30.12.2020 | ||
SE | 30.12.2020 | ||
SK | 30.12.2020 | ||
BG | 30.03.2021 | ||
NO | 30.03.2021 | ||
GR | 31.03.2021 | ||
PT | 30.04.2021 | ||
Former [2022/08] | AL | 30.12.2020 | |
AT | 30.12.2020 | ||
CZ | 30.12.2020 | ||
DK | 30.12.2020 | ||
EE | 30.12.2020 | ||
ES | 30.12.2020 | ||
FI | 30.12.2020 | ||
HR | 30.12.2020 | ||
IT | 30.12.2020 | ||
LT | 30.12.2020 | ||
LV | 30.12.2020 | ||
PL | 30.12.2020 | ||
RO | 30.12.2020 | ||
SE | 30.12.2020 | ||
SK | 30.12.2020 | ||
BG | 30.03.2021 | ||
NO | 30.03.2021 | ||
GR | 31.03.2021 | ||
IS | 30.04.2021 | ||
PT | 30.04.2021 | ||
Former [2021/49] | AL | 30.12.2020 | |
AT | 30.12.2020 | ||
CZ | 30.12.2020 | ||
DK | 30.12.2020 | ||
EE | 30.12.2020 | ||
FI | 30.12.2020 | ||
HR | 30.12.2020 | ||
IT | 30.12.2020 | ||
LT | 30.12.2020 | ||
LV | 30.12.2020 | ||
PL | 30.12.2020 | ||
RO | 30.12.2020 | ||
SE | 30.12.2020 | ||
SK | 30.12.2020 | ||
BG | 30.03.2021 | ||
NO | 30.03.2021 | ||
GR | 31.03.2021 | ||
IS | 30.04.2021 | ||
PT | 30.04.2021 | ||
Former [2021/48] | AL | 30.12.2020 | |
AT | 30.12.2020 | ||
CZ | 30.12.2020 | ||
EE | 30.12.2020 | ||
FI | 30.12.2020 | ||
HR | 30.12.2020 | ||
IT | 30.12.2020 | ||
LT | 30.12.2020 | ||
LV | 30.12.2020 | ||
PL | 30.12.2020 | ||
RO | 30.12.2020 | ||
SE | 30.12.2020 | ||
SK | 30.12.2020 | ||
BG | 30.03.2021 | ||
NO | 30.03.2021 | ||
GR | 31.03.2021 | ||
IS | 30.04.2021 | ||
PT | 30.04.2021 | ||
Former [2021/45] | AL | 30.12.2020 | |
AT | 30.12.2020 | ||
CZ | 30.12.2020 | ||
EE | 30.12.2020 | ||
FI | 30.12.2020 | ||
HR | 30.12.2020 | ||
LT | 30.12.2020 | ||
LV | 30.12.2020 | ||
PL | 30.12.2020 | ||
RO | 30.12.2020 | ||
SE | 30.12.2020 | ||
SK | 30.12.2020 | ||
BG | 30.03.2021 | ||
NO | 30.03.2021 | ||
GR | 31.03.2021 | ||
IS | 30.04.2021 | ||
PT | 30.04.2021 | ||
Former [2021/42] | AT | 30.12.2020 | |
CZ | 30.12.2020 | ||
EE | 30.12.2020 | ||
FI | 30.12.2020 | ||
HR | 30.12.2020 | ||
LT | 30.12.2020 | ||
LV | 30.12.2020 | ||
PL | 30.12.2020 | ||
RO | 30.12.2020 | ||
SE | 30.12.2020 | ||
SK | 30.12.2020 | ||
BG | 30.03.2021 | ||
NO | 30.03.2021 | ||
GR | 31.03.2021 | ||
IS | 30.04.2021 | ||
PT | 30.04.2021 | ||
Former [2021/39] | AT | 30.12.2020 | |
CZ | 30.12.2020 | ||
EE | 30.12.2020 | ||
FI | 30.12.2020 | ||
HR | 30.12.2020 | ||
LT | 30.12.2020 | ||
LV | 30.12.2020 | ||
PL | 30.12.2020 | ||
RO | 30.12.2020 | ||
SE | 30.12.2020 | ||
SK | 30.12.2020 | ||
BG | 30.03.2021 | ||
NO | 30.03.2021 | ||
GR | 31.03.2021 | ||
PT | 30.04.2021 | ||
Former [2021/37] | AT | 30.12.2020 | |
CZ | 30.12.2020 | ||
EE | 30.12.2020 | ||
FI | 30.12.2020 | ||
HR | 30.12.2020 | ||
LT | 30.12.2020 | ||
LV | 30.12.2020 | ||
RO | 30.12.2020 | ||
SE | 30.12.2020 | ||
SK | 30.12.2020 | ||
BG | 30.03.2021 | ||
NO | 30.03.2021 | ||
GR | 31.03.2021 | ||
PT | 30.04.2021 | ||
Former [2021/36] | CZ | 30.12.2020 | |
EE | 30.12.2020 | ||
FI | 30.12.2020 | ||
HR | 30.12.2020 | ||
LT | 30.12.2020 | ||
LV | 30.12.2020 | ||
RO | 30.12.2020 | ||
SE | 30.12.2020 | ||
SK | 30.12.2020 | ||
BG | 30.03.2021 | ||
NO | 30.03.2021 | ||
GR | 31.03.2021 | ||
PT | 30.04.2021 | ||
Former [2021/35] | CZ | 30.12.2020 | |
FI | 30.12.2020 | ||
HR | 30.12.2020 | ||
LT | 30.12.2020 | ||
LV | 30.12.2020 | ||
RO | 30.12.2020 | ||
SE | 30.12.2020 | ||
SK | 30.12.2020 | ||
BG | 30.03.2021 | ||
NO | 30.03.2021 | ||
GR | 31.03.2021 | ||
PT | 30.04.2021 | ||
Former [2021/33] | FI | 30.12.2020 | |
HR | 30.12.2020 | ||
LT | 30.12.2020 | ||
LV | 30.12.2020 | ||
SE | 30.12.2020 | ||
BG | 30.03.2021 | ||
NO | 30.03.2021 | ||
GR | 31.03.2021 | ||
PT | 30.04.2021 | ||
Former [2021/28] | FI | 30.12.2020 | |
HR | 30.12.2020 | ||
LV | 30.12.2020 | ||
SE | 30.12.2020 | ||
BG | 30.03.2021 | ||
NO | 30.03.2021 | ||
GR | 31.03.2021 | ||
Former [2021/23] | FI | 30.12.2020 | |
LV | 30.12.2020 | ||
SE | 30.12.2020 | ||
BG | 30.03.2021 | ||
NO | 30.03.2021 | ||
GR | 31.03.2021 | ||
Former [2021/22] | FI | 30.12.2020 | |
NO | 30.03.2021 | ||
Former [2021/20] | FI | 30.12.2020 | Documents cited: | Search | [A]WO9833812 (BRIGHAM & WOMENS HOSPITAL [US]) [A] 1-11 * claim -; sequence 52 *; | [A]US2007066514 (HABERBERGER THOMAS [US], et al) [A] 1-11* the whole document *; | [A]US2008249016 (HENRIKSEN DENNIS B [DK], et al) [A] 1-11 * claims 1-23 *; | [X]US2009023652 (BELL GREGORY [US], et al) [X] 1-4,10,11 * paragraph [0385]; table 7 *; | [A]WO2009046220 (MDRNA INC [US], et al) [A] 1-11 * claim -; sequences 106,271 * | by applicant | US5246925 | US5304121 | US5587497 | US5602116 | US5861386 | US5869473 | US5886026 | US6051567 | US6099562 | US6265392 | US6274169 | US6903083 | - Gene Expression Technology, Methods in Enzymology, Academic Press, (19910000), vol. 185 | - Gene Transfer and Expression Protocols, The Humana Press Inc., pages 109 - 128 | - SOUBERBIELLE, Kidney International, (20100000), vol. 77, pages 93 - 100 | - CHURCH et al., J. Immunol., (19820000), vol. 128, no. 5, pages 2116 - 2121 | - LAGUNOFF et al., Ann. Rev. Pharmacol. Toxicol., (19830000), vol. 23, pages 331 - 51 | - ARIDOR et al., J. Cell Biol., (19900000), vol. 111, no. 3, pages 909 - 17 | - BABINE, R. E.; BENDER, S. L., Chem. Rev., (19970000), vol. 97, page 1359 | - HANESSIAN, S. et al., Tetrahedron, (19970000), vol. 53, page 12789 | - FLETCHER, M. D.; CAMBELL, M. C., Chem. Rev., (19980000), vol. 98, page 763 | - "Methods in Molecular Medicine Series", Peptidomimetics Protocols, Humana Press, Inc., (19990000), vol. 23 | - PRAUSNITZ; LANGER, Nat. Biotechnology, (20080000), vol. 11, pages 1261 - 68 | - ARORA et al., Int. J. Pharmaceutics, (20080000), vol. 364, page 227 | - NANDA, Current Drug Delivery, (20060000), vol. 3, page 233 | - MEIDAN et al., American J. Therapeutics, (20040000), vol. 11, page 312 | - NANDA et al., Current Drug Delivery, (20060000), vol. 3, page 233 | - NEMETH et al., J. Pharmacol. Exp. Ther., (20040000), vol. 308, no. 2, pages 627 - 35 |